CBT Pharmaceuticals begins phase I study of CBT-501 in advanced, relapsed or recurrent solid tumors March 20, 2017
New trial to combine Reolysin with Imnovid or Revlimid in patients with relapsing myeloma March 17, 2017
Bellicum initiates phase I study of BPX-701 in relapsed or refractory myeloid neoplasms March 17, 2017
Mayo Clinic secures grant to study TapImmune's HER2-targeted vaccine for ductal carcinoma in situ March 15, 2017
Phase Ib data warrant progression of Heat Biologics' trial of HS-110 with nivolumab in NSCLC March 14, 2017
RSS